Synoligo Biotechnologies, Inc.

Biotechnology company · Morrisville, North Carolina, United States

Synoligo Biotechnologies, Inc. is a biotechnology company headquartered in Morrisville, North Carolina, United States. Its earliest recorded incorporation is in 2022. It has reported private securities offerings to the US SEC, most recently $7 million sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Synoligo Biotechnologies at a glance

Typebiotechnology company

HeadquartersMorrisville, North Carolina, United States

Earliest incorporation on record2022

SEC CIK1943776

What does Synoligo Biotechnologies do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $7 million sold (2022).

Frequently asked questions about Synoligo Biotechnologies

Where is Synoligo Biotechnologies headquartered?

Synoligo Biotechnologies, Inc. is headquartered in Morrisville, North Carolina, United States.

What does Synoligo Biotechnologies do?

Synoligo Biotechnologies, Inc. is a biotechnology company.

When was Synoligo Biotechnologies founded?

The earliest incorporation on record for Synoligo Biotechnologies, Inc. is in 2022, according to public company registers.

Similar companies

Civatech Oncology, Inc.Morrisville, North Carolina, United States
Kriya Therapeutics, Inc.Morrisville, North Carolina, United States
Vast TherapeuticsMorrisville, North Carolina, United States
Locus Biosciences, Inc.Morrisville, North Carolina, United States
Istari Oncology, Inc.Morrisville, North Carolina, United States
Affinergy, LLCMorrisville, North Carolina, United States
Envisia Therapeutics, Inc.Morrisville, North Carolina, United States
Attagene, Inc.Morrisville, North Carolina, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences